Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Head and Neck Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Head and Neck Cancer
    TopAbstracts in Head and Neck Cancer 11/13/2008 - (DGNews)
    TopAbstracts in Head and Neck Cancer 10/30/2008 - (DGNews)
    Health Canada Approves Cetuximab for Advanced Colorectal Cancer, Head and Neck Cancer - (DGNews)
    Chest Scans May Help Monitor Spread of Head and Neck Cancer in High-Risk Patients - (DGNews)
    TopAbstracts in Head and Neck Cancer 10/16/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Head and Neck Cancer

    Webcasts/CME archive

     Recent cases - Head and Neck Cancer
      Fibrosarcoma of the Childhood Mandible
      Follicular Dendritic Cell Sarcoma of the Neck: Report of a Case Treated By Surgical Excision and COP Plus (PEG)-Liposomal Doxorubicin
      The Buccal Minor Salivary Glands as Starting Point for a Metastasizing Adenocarcinoma - Report of a Case
      Unusual Clear Cell Tumours of the Jaws - Clinical and Histopathological Considerations: A Case Report
      Radiofrequency-Induced Thermotherapy of Nasopharyngeal Angiofibroma and Immunohistochemical Analysis of Vessel Proliferation: A Case Report

      Cases archive
        




      my personal edition > head and neck cancer > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Patient Demographics Influence Treatment and Survival in Laryngeal Cancer: Presented at AHNS

      By Arushi Sinha

      SAN FRANCISCO -- July 24, 2008 -- Early detection of laryngeal carcinoma appears to result in better outcomes, and patients with access to health insurance appear to be diagnosed earlier than patients without insurance, researchers indicated here at the American Head and Neck Society (AHNS) 7th International Conference on Head and Neck Cancer.

      The study was a retrospective cohort analysis using statewide data from the South Carolina Central Cancer Registry and Office of Research Statistics medical claims records. The main outcomes of interest were stage at diagnosis, main treatment modality, and survival.

      Lawrence Yen, MD, Chairman, Department of Otolaryngology -- Head and Neck Surgery, Buddhist Tzuchi General Hospital, Taipei, Taiwan, presented the study findings in a poster session on July 22.

      While there is much speculation about the role of patient characteristics -- including race -- on cancer outcomes, there are fewer systematic studies on the mechanisms by which this may occur, Dr. Yen said. "We asked the question: Are there racial differences in diagnosis?" he explained.

      The study analysed the stage of diagnosis, treatment protocols, and survival outcomes of 548 patients with newly diagnosed laryngeal cancer. Patients were racially diverse: 68.8% were white and 31.2% African Americans.

      African Americans were 17% less likely than whites to have their cancer diagnosed at an early stage and were 14% more likely to undergo surgical treatment, although these findings were not statistically significant.

      By contrast, the structural components of patient healthcare -- such as access to insurance and distance from a major medical facility -- did prove to be significantly different according to the patient's race. Those who had either public insurance (odds ratio [OR] = 2.18) or private insurance (OR = 2.86) were more likely to have an early diagnosis of laryngeal carcinoma compared with those who had no insurance. And those who were married (OR = 1.53) were diagnosed earlier than those who were not married.

      Patients who lived in a rural community (OR = 1.59) or had local tumour spread (OR = 1.95) were more likely to receive surgical treatment and possible loss of laryngeal function.

      Both surgery (hazard ratio [HR] = 0.15) and radiotherapy (HR = 0.17) techniques significantly improved patient survival.

      "Race seems like a factor only because African Americans have more late-stage disease at presentation or because they live in rural areas and are therefore more likely to receive surgical therapy," explained Dr. Yen.

      The authors stated that health policy needs to focus on a more equitable allocation of healthcare resources.

      "The outcomes don't have much to do with race. It turns out to be common sense, really," said Dr. Yen. For their innovative research, the presentation received an award of distinction from the conference committee.

      [Presentation title: Racial Difference in the Diagnosis, Treatment and Survival of Laryngeal Cancer Patients. Abstract P600]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send